STAT+：非营利组织在初创公司倒闭后重启被搁置的基因疗法
摘要
想随时了解当今推动生物技术发展的科学与政策动态吗？请注册以获取我们的生物技术新闻通讯，直达您的邮箱。早上好。继续阅读，了解我的同事在宾夕法尼亚州荷兰人聚居区的所见所闻，以及诺和诺德与礼来之间最新争端的来龙去脉。一个门诺教派社区正致力于解决生物技术领域最棘手的问题之一。在宾夕法尼亚州荷兰人聚居区，一位医生长期与生物技术公司和学术界合作，为当地阿米什和门诺教派社区中病情最重的儿童开发基因疗法。继续阅读STAT+以获取完整报道……
English
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Read on to find out what my colleague was doing in Pennsylvania Dutch country and what the latest dispute between Novo and Lilly is all about. A Mennonite community is set on solving one of biotech’s most vexing problems In Pennsylvania Dutch country, one doctor has long been working with biotech companies and academics to develop gene therapies for the sickest children in local Amish and Mennonite communities. Continue to STAT+ to read the full story…